Showing results (341-350 of 413) with videos related to

Sort By:
Pageof 42
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Clinical Epigenetics|November 12, 2020
Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assaysCarolin Dippmann, Martina Schmitz, Kristina Wunsch, et al.
Genes, Chromosomes & Cancer|October 22, 2019
Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differencesJosefine Beiersdorf, Cornelia Scheungraber, Kristina Wunsch, et al.
Cancer Genetics|January 31, 2012
Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinomaClaudia Backsch, Birgit Pauly, Melanie Liesenfeld, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Breast Cancer Research and Treatment|January 21, 2010
The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancerDiane M Renz, Joachim Böttcher, Pascal A T Baltzer, et al.
Cancer Gene Therapy|June 26, 2002
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerRichard E Buller, Ingo B Runnebaum, Beth Y Karlan, et al.
American Journal of Medical Genetics. Part A|May 25, 2013
Cardiac fat-containing lesions are common in tuberous sclerosis complexElias A Shaaya, Jacqueline S Hirshberg, Olivia T Rabe, et al.
Cancer Gene Therapy|June 26, 2002
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500Richard E Buller, Mark S Shahin, Jo Ann Horowitz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 16, 2008
[Clinical value of computer-assisted analysis in MR mammography. A comparison between two systems and three observers with different levels of experience]D M Renz, P A T Baltzer, P E Kullnig, et al.
Pageof 42